D&D Pharmatech Inc. (KOSDAQ:347850)

D&D Pharmatech Revenue

D&D Pharmatech had revenue of 128.78M KRW in the quarter ending March 31, 2026, a decrease of -90.89%. This brings the company's revenue in the last twelve months to 3.01B, down -71.91% year-over-year. In the year 2025, D&D Pharmatech had annual revenue of 4.30B, down -62.42%.

• Revenue (ttm): 3.01B
• Revenue Growth: -71.91%
• P/S Ratio: 1,363.55
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 4.11T

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	4.30B	-7.14B	-62.42%
Dec 31, 2024	11.44B	-7.24B	-38.77%
Dec 31, 2023	18.68B	18.07B	2,958.97%
Dec 31, 2022	610.57M	-753.54M	-55.24%
Dec 31, 2021	1.36B	-	-

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 29, 2026

Data Sources Report a data error